Thinking of joining a study?

Register your interest

Become a volunteer?

NCT03413982 | RECRUITING | Bladder Cancer

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
Sponsor:

University of Kansas Medical Center

Brief Summary:

The purpose of this study is to create a registry, which is a "bank" of information about patients who have had similar medical conditions and treatments. The registry will be used by researchers to learn more about long term outcome of patients with bladder cancer, how bladder cancer tissues are related to tumor development, recurrence and survival.

Condition or disease

Bladder Cancer

Intervention/treatment

Registry

Study Type : OBSERVATIONAL
Estimated Enrollment : 1000 participants
Official Title : Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
Actual Study Start Date : 2017-11-02
Estimated Primary Completion Date : 2030-01-01
Estimated Study Completion Date : 2035-01-01

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Patients who present to clinic with presumed bladder cancer or have a diagnosis of bladder cancer are eligible to participate
  • * Patients can participate in any additional research studies during the patients' participation within this protocol.
Exclusion Criteria
  • * Patients who do not have presumed bladder cancer will not be eligible
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

Location Details

NCT03413982

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

RECRUITING

United States, Kansas

University of Kansas Medical Center

Kansas City, Kansas, United States, 66160